Risk and Outcome of Venous and Arterial Thrombosis in Patients With Cirrhosis: A Danish Nation-wide Cohort Study.
Journal
Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
revised:
06
06
2021
received:
22
02
2021
accepted:
13
06
2021
pubmed:
18
6
2021
medline:
14
1
2022
entrez:
17
6
2021
Statut:
ppublish
Résumé
Cirrhosis affects hemostasis, but its effects across the spectrum of thromboses remain poorly understood. We examined risks and outcomes of venous and arterial thrombosis. We used nation-wide Danish health care registries to identify outpatients with cirrhosis and a sex- and age-matched comparison cohort without cirrhosis from the general population. Patients with cirrhosis and comparators were followed until they had a venous thromboembolism (VTE), acute myocardial infarction (AMI), or ischemic stroke (IS) or died. We computed absolute risks and HRs of thrombosis and compared outcomes after thrombosis. We included 5,854 patients with cirrhosis (median Model for End-Stage Liver Disease score, 9; interquartile range, 7-13), and their risk of any of the thrombotic events was 0.8% after 1 year and 6.3% after 10 years. They were more likely than the 23,870 matched comparators to have a VTE (adjusted hazard ratio [aHR], 2.0; 95% CI, 1.5-2.6) or IS (aHR, 1.7; 95% CI, 1.3-2.3), but not AMI (aHR, 0.7; 95% CI, 0.5-0.9). Among patients with cirrhosis, decompensation increased the risk of AMI, but not the other thromboses. Following thrombosis, patients with cirrhosis had higher 90-day mortality than comparators (after VTE: 17% vs. 7%; after AMI: 27% vs. 5%; after IS: 10% vs. 7%) and were less likely to receive antithrombotic treatment. Patients with cirrhosis had an increased risk of VTE and IS, but not AMI. Among patients with cirrhosis, decompensation increased the risk of AMI, exclusively. Mortality after thrombosis was higher in patients with cirrhosis than in other patients. These findings are relevant for decisions about antithrombotic prophylaxis in patients with cirrhosis.
Sections du résumé
BACKGROUND AND AIMS
Cirrhosis affects hemostasis, but its effects across the spectrum of thromboses remain poorly understood. We examined risks and outcomes of venous and arterial thrombosis.
APPROACH AND RESULTS
We used nation-wide Danish health care registries to identify outpatients with cirrhosis and a sex- and age-matched comparison cohort without cirrhosis from the general population. Patients with cirrhosis and comparators were followed until they had a venous thromboembolism (VTE), acute myocardial infarction (AMI), or ischemic stroke (IS) or died. We computed absolute risks and HRs of thrombosis and compared outcomes after thrombosis. We included 5,854 patients with cirrhosis (median Model for End-Stage Liver Disease score, 9; interquartile range, 7-13), and their risk of any of the thrombotic events was 0.8% after 1 year and 6.3% after 10 years. They were more likely than the 23,870 matched comparators to have a VTE (adjusted hazard ratio [aHR], 2.0; 95% CI, 1.5-2.6) or IS (aHR, 1.7; 95% CI, 1.3-2.3), but not AMI (aHR, 0.7; 95% CI, 0.5-0.9). Among patients with cirrhosis, decompensation increased the risk of AMI, but not the other thromboses. Following thrombosis, patients with cirrhosis had higher 90-day mortality than comparators (after VTE: 17% vs. 7%; after AMI: 27% vs. 5%; after IS: 10% vs. 7%) and were less likely to receive antithrombotic treatment.
CONCLUSIONS
Patients with cirrhosis had an increased risk of VTE and IS, but not AMI. Among patients with cirrhosis, decompensation increased the risk of AMI, exclusively. Mortality after thrombosis was higher in patients with cirrhosis than in other patients. These findings are relevant for decisions about antithrombotic prophylaxis in patients with cirrhosis.
Identifiants
pubmed: 34137045
doi: 10.1002/hep.32019
pmc: PMC8542589
mid: NIHMS1716587
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2725-2734Subventions
Organisme : NIDDK NIH HHS
ID : K23 DK117055
Pays : United States
Informations de copyright
© 2021 by the American Association for the Study of Liver Diseases.
Références
Int J Cardiol. 2020 Jun 1;308:1-8
pubmed: 32057473
J Hepatol. 2017 Jun;66(6):1313-1326
pubmed: 28088580
Hepatology. 2015 Feb;61(2):660-7
pubmed: 25284616
Clin Transl Gastroenterol. 2015 Jul 02;6:e97
pubmed: 26133110
Gastroenterology. 2009 Dec;137(6):2105-11
pubmed: 19706293
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1064-74
pubmed: 23506859
JAMA Neurol. 2017 Aug 1;74(8):927-932
pubmed: 28586894
Lancet. 2017 Dec 17;388(10063):3060-3073
pubmed: 27375038
Scand J Gastroenterol. 2013 May;48(5):585-91
pubmed: 23506154
Catheter Cardiovasc Interv. 2020 Oct 1;96(4):802-810
pubmed: 31713989
N Engl J Med. 2004 Sep 23;351(13):1296-305
pubmed: 15385656
Semin Thromb Hemost. 2013 Jun;39(4):426-33
pubmed: 23487343
Int J Epidemiol. 2017 Jun 1;46(3):798-798f
pubmed: 27789670
BMC Gastroenterol. 2008 Feb 09;8:3
pubmed: 18261240
J Invasive Cardiol. 2019 Jul;31(7):E162-E169
pubmed: 31257209
Gut. 2012 Jul;61(7):967-9
pubmed: 22234982
Hepatology. 2010 May;51(5):1675-82
pubmed: 20186844
Hepatology. 2008 Jul;48(1):214-20
pubmed: 18537190
Clin Epidemiol. 2019 Jul 12;11:563-591
pubmed: 31372058
Lancet. 2020 Jul 11;396(10244):129-142
pubmed: 32653056
Dig Dis Sci. 2018 May;63(5):1355-1362
pubmed: 29516327
J Clin Epidemiol. 2002 Jun;55(6):602-7
pubmed: 12063102
J Clin Epidemiol. 2014 Aug;67(8):921-31
pubmed: 24794575
N Engl J Med. 2011 Jul 14;365(2):147-56
pubmed: 21751907
Lancet Haematol. 2018 Oct;5(10):e441-e449
pubmed: 30201587
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
Eur J Epidemiol. 2014 Aug;29(8):541-9
pubmed: 24965263
J Clin Gastroenterol. 2020 Jan;54(1):96-105
pubmed: 30882537
Eur J Clin Invest. 2020 Apr;50(4):e13205
pubmed: 31994180
Eur J Clin Invest. 2017 Aug;47(8):565-573
pubmed: 28657113
Clin Epidemiol. 2020 May 18;12:469-475
pubmed: 32547238
Neuroepidemiology. 2007;28(3):150-4
pubmed: 17478969
Gastroenterology. 2012 Nov;143(5):1253-1260.e4
pubmed: 22819864
Gut. 2010 Jan;59(1):105-10
pubmed: 19837678
BMJ Open. 2016 Nov 18;6(11):e012832
pubmed: 27864249
J Med Syst. 1997 Feb;21(1):11-20
pubmed: 9172066
Gastroenterology. 2017 Aug;153(2):480-487.e1
pubmed: 28479379
Dig Dis Sci. 2011 Jul;56(7):2152-9
pubmed: 21279685
Am J Gastroenterol. 2009 Jan;104(1):96-101
pubmed: 19098856
Thromb Haemost. 2017 Jan 5;117(1):139-148
pubmed: 27761574
Scand J Gastroenterol. 2012 Jun;47(6):702-9
pubmed: 22428859